Table 1. Characteristics and results of the included studies.
| Study | Country | No.of P.(1097) | Method | FIGOStage (Ⅰ-Ⅱ/Ⅲ-Ⅳ) | tumor grade(G1/G2/G3) | lymph nodly metastasis(yes /no) | Survivin(+) | NOS | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ovarian carcinoma | Borderline ovarian tumor | Ovarian benign tumor | Normal ovarian tissues | ||||||||
| Sui[11]2002 | Japan | 103 | IHC | 19/28 | 21/13/13 | 24/19 | 24 | 11 | 7 | 7 | |
| Ju LL[16]2016 | China | 60 | IHC | 19/20 | 8/31* | 8 | 3 | 1 | 8 | ||
| Kanter M[17]2016 | Turkey | 98 | IHC | 37 | 4 | 3 | 8 | ||||
| Plewka D[18]2015 | Europe | 157 | IHC | 41 | 22 | 13 | 0 | 6 | |||
| Turan G[19]2014 | Turkey | 62 | IHC | 21 | 10 | 6 | 8 | ||||
| Qian X[20]2011 | China | 91 | IHC | 55 | 4 | 0 | 7 | ||||
| Huang Y[21]2011 | China | 65 | IHC | 7/18 | 2/23* | 26 | 6 | 5 | 8 | ||
| Liguang Z[22]2007 | China | 114 | RT-PCR | 28/35 | 30Δ/33 | 34/29 | 46 | 9 | 4 | 0 | 6 |
| Gao Q[23]2007 | China | 70 | IHC | 10/36 | 22Δ/24 | 28 | 5 | 0 | 7 | ||
| Yin RT[24]2006 | China | 69 | IHC | 10/28 | 13Δ/25 | 18/13 | 29 | 9 | 0 | 7 | |
| Ma XY[25]2006 | China | 143 | IHC | 41/43 | 32/34/18 | 53 | 12 | 0 | 7 | ||
| Zhang SL[26]2003 | China | 65 | RT-PCR | 14/21 | 24Δ/11 | 13/22 | 29 | 8 | 2 | 0 | 6 |
*, G2-G3
Δ, G1-G2
No. of P, number of patients; NOS, Newcastle-Ottawa quality assessment scale; RT-PCR, reverse transcription polymerase chain reaction; IHC, immunohistochemistry